Treat HSDD Condition in Women Using Fili 100mg
Hypoactive Sensual Desire Disorder (HSDD) is a common sensual dysfunction in women, characterized by a persistent or recurrent deficiency or absence of sensual fantasies or desire for sensual activity. The prevalence of HSDD is approximately 10-15% in women of all ages. The condition can significantly affect the quality of life and lead to relationship problems. In recent years, several medications have been developed to treat HSDD, including Flibanserin 100mg, also known as Fili 100. Fili 100mg - A Brief Overview: Fili 100mg is a medication approved by the FDA for treating HSDD in premenopausal women. It is a non-hormonal, selective serotonin receptor agonist and antagonist. The medication is also known by its brand name Addyi. Fili 100 works by increasing dopamine and norepinephrine levels while decreasing the serotonin level in the brain. These neurotransmitters are responsible for regulating mood, pleasure, and sensual desire. Fili 100mg was first approved by the FDA in 2015....